908 Devices (MASS) Share-based Compensation Growth (1y) (2021 - 2026)
908 Devices (MASS) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 18.31% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -78.13% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 16.00% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 12.53% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -13.91% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 60.71% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 5.29% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.56% |
| 10 | 908 Devices | 387.65 Mn | 286.12 Mn | 8.34 Mn | -0.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.98% |
| Mar 31, 2026 | 440.54% |
| Dec 31, 2025 | 619.01% |
| Sep 30, 2025 | 326.09% |
| Jun 30, 2025 | 4.80% |
| Mar 31, 2025 | 20.72% |
| Dec 31, 2024 | -121.59% |
| Sep 30, 2024 | -14.94% |
| Jun 30, 2024 | -13.54% |
| Mar 31, 2024 | -15.10% |
| Dec 31, 2023 | 16.72% |
| Sep 30, 2023 | 33.86% |
| Jun 30, 2023 | 36.11% |
| Mar 31, 2023 | 68.04% |
| Dec 31, 2022 | 129.55% |
| Sep 30, 2022 | 149.08% |
| Jun 30, 2022 | 293.76% |
| Mar 31, 2022 | 280.24% |
| Dec 31, 2021 | 184.36% |
| Sep 30, 2021 | 877.11% |